A detailed history of Black Rock Inc. transactions in Siga Technologies Inc stock. As of the latest transaction made, Black Rock Inc. holds 3,455,309 shares of SIGA stock, worth $25.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,455,309
Previous 3,513,890 1.67%
Holding current value
$25.5 Million
Previous $19.7 Million 50.31%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$4.51 - $8.92 $264,200 - $522,542
-58,581 Reduced 1.67%
3,455,309 $29.6 Million
Q4 2023

Feb 13, 2024

BUY
$4.82 - $6.25 $720,965 - $934,862
149,578 Added 4.45%
3,513,890 $19.7 Million
Q3 2023

Nov 13, 2023

BUY
$4.32 - $5.77 $546,233 - $729,576
126,443 Added 3.91%
3,364,312 $17.7 Million
Q2 2023

Aug 11, 2023

BUY
$5.0 - $6.31 $219,365 - $276,838
43,873 Added 1.37%
3,237,869 $16.4 Million
Q1 2023

May 12, 2023

SELL
$5.23 - $8.42 $548,187 - $882,550
-104,816 Reduced 3.18%
3,193,996 $18.4 Million
Q4 2022

Feb 13, 2023

BUY
$7.29 - $10.14 $707,071 - $983,498
96,992 Added 3.03%
3,298,812 $24.3 Million
Q3 2022

Nov 14, 2022

SELL
$10.02 - $26.15 $2.18 Million - $5.69 Million
-217,513 Reduced 6.36%
3,201,820 $33 Million
Q2 2022

Aug 12, 2022

SELL
$6.5 - $13.68 $1.1 Million - $2.31 Million
-168,522 Reduced 4.7%
3,419,333 $39.6 Million
Q1 2022

May 12, 2022

SELL
$5.96 - $7.61 $819,309 - $1.05 Million
-137,468 Reduced 3.69%
3,587,855 $25.4 Million
Q4 2021

Feb 10, 2022

SELL
$6.96 - $9.26 $2.59 Million - $3.44 Million
-371,680 Reduced 9.07%
3,725,323 $28 Million
Q3 2021

Nov 09, 2021

BUY
$5.71 - $7.39 $936,993 - $1.21 Million
164,097 Added 4.17%
4,097,003 $30.3 Million
Q2 2021

Aug 11, 2021

BUY
$6.1 - $7.58 $24 Million - $29.8 Million
3,932,906 New
3,932,906 $24.7 Million

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $538M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.